Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Pharma & Biotech
Next-Generation Programmable mRNA Therapies Post COVID-19 with Jacob Becraft of Strand Therapeutics
New Podcast Episode: DeciBio interviews Jacob Becraft, the CEO and co-founder of Strand Therapeutics.
June 22, 2022
DeciBio Q&A
Pharma & Biotech
Next-Generation Programmable mRNA Therapies Post COVID-19 with Jacob Becraft of Strand Therapeutics
New Podcast Episode: DeciBio interviews Jacob Becraft, the CEO and co-founder of Strand Therapeutics.
June 22, 2022
Next-Generation Therapeutics
Precision Medicine
Infographic
Clinical Diagnostics
The Precision Oncology Landscape Infographic [Updated June 2022]
The precision oncology landscape is getting crowded, with an increasing number of players offering solutions throughout the diagnostic and treatment journey.
June 14, 2022
Infographic
Clinical Diagnostics
The Precision Oncology Landscape Infographic [Updated June 2022]
The precision oncology landscape is getting crowded, with an increasing number of players offering solutions throughout the diagnostic and treatment journey.
June 14, 2022
Clinical Diagnostics
Companion Diagnostics
ctDNA
DeciBio Data Insights
DeciBio Q&A
Clinical Diagnostics
Cell Therapy Trends: ArsenalBio's differentiation strategy and long-term plans with Tarjei Mikkelsen
We had the chance to talk with Tarjei Mikkelsen PhD, CTO at ArsenalBio, a programmable cell therapy company, to get his thoughts on the cell therapy field.
June 13, 2022
DeciBio Q&A
Clinical Diagnostics
Cell Therapy Trends: ArsenalBio's differentiation strategy and long-term plans with Tarjei Mikkelsen
We had the chance to talk with Tarjei Mikkelsen PhD, CTO at ArsenalBio, a programmable cell therapy company, to get his thoughts on the cell therapy field.
June 13, 2022
Cell & Gene Tx
Blog Article
Research Tools
AGBT 2022: DeciBio Highlights – Back to Technological Innovation
The level of new announcements and innovation was one of the most impressive in recent memory and appeared non-linear compared to previous years.
June 10, 2022
Blog Article
Research Tools
AGBT 2022: DeciBio Highlights – Back to Technological Innovation
The level of new announcements and innovation was one of the most impressive in recent memory and appeared non-linear compared to previous years.
June 10, 2022
Research Tools
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | May Roundup
This month we have seen major new trial developments and partnership changes in the cell therapy space, creative funding rounds across gene therapies, and significant manufacturing expansions for oligonucleotide therapies.
June 8, 2022
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | May Roundup
This month we have seen major new trial developments and partnership changes in the cell therapy space, creative funding rounds across gene therapies, and significant manufacturing expansions for oligonucleotide therapies.
June 8, 2022
Next-Generation Therapeutics
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | May Roundup
Liquid Biopsy (LBx) continued to develop through May, featuring new CE-IVD and FDA approvals, research and commercialization collaborations, and new trial launches and study results.
June 1, 2022
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | May Roundup
Liquid Biopsy (LBx) continued to develop through May, featuring new CE-IVD and FDA approvals, research and commercialization collaborations, and new trial launches and study results.
June 1, 2022
Liquid Biopsy
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved